Annette F Favorite, Senior Vice President & Chief Human Resources Officer, on April 27, 2026, sold 2,817 shares in West Pharmaceutical Services (WST) for $859,753. Following the Form 4 filing with the SEC, Favorite has control over a total of 21,795 common shares of the company, with 16,828 shares held directly and 4,967 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/105770/000010577026000054/xslF345X05/form4.xml
Price: $294.39, Change: $+2.47, Percent Change: +0.85%
James Edgemond, CFO and Treasurer, on April 27, 2026, sold 10,000 shares in United Therapeutics (UTHR) for $5,688,319. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000163617826000013/xslF345X05/primarydocument.xml
Martin Roper, Director, Chief Executive Officer, on April 24, 2026, sold 50,000 shares in Vita Coco Company (COCO) for $2,500,000. Following the Form 4 filing with the SEC, Roper has control over a total of 987,577 common shares of the company, with 298,484 shares held directly and 689,093 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1482981/000148298126000114/xslF345X05/form4.xml
Russell Barrett, Senior Executive Vice President, Chief Operating Officer, on April 27, 2026, sold 90,537 shares in Valley National Bancorp (VLY) for $1,225,871. Following the Form 4 filing with the SEC, Barrett has control over a total of 64,167 common shares of the company, with 64,167 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/714310/000200688626000005/xslF345X05/wk-form4_1777410703.xml